INT J BIOL MARKER 润色咨询

The International Journal of Biological Markers

出版年份:1986 年文章数:51 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:9.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2023-04-12 123fdaafm54(暂无昵称) 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;生物学标记物
    经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2023-04-17 123fdaafm54(暂无昵称) 来自广东省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤
    经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2022-05-03 ms9000000372271319

    审稿速度:3.0
    经验分享:19-Jan-2022提交
    28-Jan-2022改格式后提交
    28-Mar-2022小修
    05-Apr-2022接收
    29-Apr-2022可查

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-11-19 ms9000002047508352

    Awaiting Reviewer Selection 是什么意思啊,送外审了吗?

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2023-02-21 ms1000000882251215

    偏重的研究方向:肿瘤
    经验分享:需要原始数据吗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2022-02-15 zbwwh

    需要提交原始数据吗

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-10-25  筝之韵

    多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-10-25 海洋与蓝天

    经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-10-25 敬颂安吉

    审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物学标记物<br>经验分享:各位大佬,Awaiting Reviewer Assignment的状态已经持续2周,是代表已经送审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:刚Awaiting Reviewer Selection,第二天的状态就变成了Awaiting Decision是不是要拒了,没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0<br>经验分享:19-Jan-2022提交<br>28-Jan-2022改格式后提交<br>28-Mar-2022小修<br>05-Apr-2022接收<br>29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊,送外审了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向:肿瘤<br>经验分享:需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学,多问,审稿时间还好,多注意审稿人建议,这期刊可以的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享:历时8个月顺利投稿,非常感谢网友老师的热心回复,很有帮助。我的经验还是要多看多问吧<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063797, encodeId=d2ec1063e97e5, content=审稿很严谨的,多精进一下写作,真的会快一些的,过来人分享。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=敬颂安吉, createdTime=Mon Oct 25 16:11:26 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062861, encodeId=3177106286177, content="审稿速度:3.0 | 投稿命中率:75.0<br>接收拉,审核挺严谨的,一审2个月的样子"<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=Grace2021, createdTime=Fri Oct 22 09:39:19 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-10-22 Grace2021

    "审稿速度:3.0 | 投稿命中率:75.0
    接收拉,审核挺严谨的,一审2个月的样子"

    1

    展开1条回复
共40条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分